1. Organization, W.H. and S.T. Initiative, Treatment of tuberculosis: guidelines. 2019: World Health
Organization.
2. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human
immunodeficiency virus infection after tuberculosis. American journal of respiratory and critical care
medicine. 1995 Jan;151(1):129-35.
3. Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. The
Lancet infectious diseases. 2010 Jul 1;10(7):455-63.
4. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH. A
prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency
virus infection. New England journal of medicine. 1989 Mar 2;320(9):545-50.
5. Nakata KO, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M. Mycobacterium tuberculosis
enhances human immunodeficiency virus-1 replication in the lung. American journal of respiratory and critical
care medicine. 1997 Mar;155(3):996-1003.
6. Aaron L, Saadoun D, Calatroni I, Launay O, Memain N, Vincent V, Marchal G, Dupont B, Bouchaud O,
Valeyre D, Lortholary O. Tuberculosis in HIV-infected patients: a comprehensive review. Clinical
microbiology and infection. 2004 May 1;10(5):388-98.
7. Chen CY, Huang D, Wang RC, Shen L, Zeng G, Yao S, Shen Y, Halliday L, Fortman J, McAllister M, Estep
J. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog. 2009 Apr
17;5(4):e1000392.
8. Lewinsohn DA, Winata E, Swarbrick GM, Tanner KE, Cook MS, Null MD, Cansler ME, Sette A, Sidney J,
Lewinsohn DM. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLOS
pathog. 2007 Sep 21;3(9):e127.
9. Kamath R, Sharma V, Pattanshetty S, Hegde MB, Chandrasekaran V. HIV-TB coinfection: Clinicoepidemiological determinants at an antiretroviral therapy center in Southern India. Lung India: official organ
of Indian Chest Society. 2013 Oct;30(4):302.
10. Batyrov FA, Frolova OP, Zhukova GN, Sementsova IG, Mukhanova OI. A category of patients with
tuberculosis concomitant with HIV infection in an anti-TB facility. Problemy tuberkuleza i boleznei legkikh.
2003 Jan 1(5):6-9.
11. Rasoolinejad M, Hadadi A, Yaghoobi MH, Badie BM, Alijani N. Outcome of TB in HIV patients treated with
standard regimen. Tehran University Medical Journal. 2013 Oct 1;71(7).
12. Hadadi A, Rasoolinejad M, Davoudi S, Nikdel M, Rasteh M. Clinical characteristics of pulmonary
tuberculosis in patients with HIV/AIDS: a case-control study. Tehran University Medical Journal TUMS
Publications. 2006 Aug 10;64(5):87-95.
13. Tabarsi P, Mirsaeidi SM, Amiri M, Mansouri SD, Masjedi MR, Velayati AA. Clinical and laboratory profile of
patients with tuberculosis/HIV coinfection at a national referral centre: a case series. Eastern Mediterranean
Health Journal. 2008 Mar 1;14(2).